FDA approves suzetrigine, the first new painkiller since 1998
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.
FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which she experienced when taking opioids.
PCMag on MSN58m
Chinese-Made Patient Monitor Contains a Secret Backdoor
The backdoor on Contec CMS8000 patient-monitoring devices could allow an IP address at an unnamed university to remotely ...
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternative
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...
The Mirror US on MSN51m
Chocolate recall escalates as FDA warns of 'life-threatening risk' - what to know
Officials with the U.S. Food and Drug Administration have officially escalated a chocolate recall initially issued in ...
Hosted on MSN15m
New type of non-opioid pain medication approved by FDA
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Red dye #3, banned for cancer risk, linked to behavioral problems in children
A ThedaCare pediatrician says red dye #3 can cause behaviors associated with ADHD, even in kids who don't have it.